NewGenIvf (NIVF) Revenue (2024 - 2025)
NewGenIvf (NIVF) posted quarterly Revenue of $1.4 million for Q4 2025, up 11.85% year-over-year from $1.3 million in Q4 2024, and up 11.1% quarter-over-quarter from $1.3 million in Q3 2025.
NewGenIvf (NIVF) Revenue (2024 - 2025) Analysis & Trends
NewGenIvf (NIVF) has reported Revenue for 2 consecutive years, with $1.4 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Revenue rose 11.85% year-over-year to $1.4 million; the TTM figure through Dec 2025 stood at $5.5 million (changed N/A YoY), while the FY2025 annual figure was $4.7 million, down 13.01% from the prior year.
- Revenue advanced to $1.4 million in Q4 2025 per NIVF's latest filing, from $1.3 million in the prior quarter.
- Across five years, Revenue topped out at $1.5 million in Q3 2024 and bottomed at $1.3 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 89.17 Bn | 88.16 Bn | 15.19 Bn | 20.23 Bn |
| 2 | Tenet Healthcare | 22.30 Bn | 20.13 Bn | 4.45 Bn | 5.63 Bn |
| 3 | Encompass Health | 12.22 Bn | 12.08 Bn | 1.34 Bn | 1.60 Bn |
| 4 | Davita | 11.68 Bn | 10.99 Bn | 1.16 Bn | 3.55 Bn |
| 5 | Ensign | 10.53 Bn | 10.21 Bn | 306.24 Mn | 1.44 Bn |
| 6 | Universal Health Services | 10.14 Bn | 10.00 Bn | 3.29 Bn | 4.64 Bn |
| 7 | Pacs | 7.07 Bn | 6.91 Bn | 338.46 Mn | 1.43 Bn |
| 8 | Chemed | 7.04 Bn | 7.00 Bn | 221.47 Mn | 673.25 Mn |
| 9 | Fresenius Medical Care AG | 6.38 Bn | 4.69 Bn | 1.52 Bn | 5.65 Bn |
| 10 | NewGenIvf | 8,983.83 | -784,624.17 | 524,025.00 | 1.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.42 Mn |
| Sep 30, 2025 | 1.28 Mn |
| Dec 31, 2024 | 1.27 Mn |
| Sep 30, 2024 | 1.47 Mn |